MyLife Technologies secures new growth capital, 14 November 2016
A consortium of informal investors has invested 0.5 million € in MyLife Technologies, a med tech company developing dermal delivery solutions based on its platform technology of ceramic nano-porous MicroNeedle Arrays (npMNA). MyLife Technologies will use this investment to accelerate the development of pharmaceutical applications of its npMNA technology.
The company focuses on applications in the field of prophylactic vaccines, therapeutic vaccines and specific small molecules. The npMNAs are made of biocompatible ceramic material and are combined with a dermal patch, allowing easy self-application by the patient. The nanopores of the MNA devices are used for storage of pharmaceutical compounds. This minimally invasive application method is pain-free and is an effective way to overcome the stratum corneum, the skin’s main barrier.
MyLife Technologies is a spin-off from University of Twente, MESA+, Institute for Nanotechnology, The Netherlands. In June 2015, the company opened its own lab in the facilities of BioPartner Center at Leiden Bio Science Park. Technology patents have been obtained in Europe, USA, Japan and China.
CEO Pieter Jan Vos is very pleased: “This new capital is an important milestone for MyLife Technologies. It allows us to expand our lab facilities and our team. We will intensify and expand our development pipeline”.
Download full Press Release
C.J. Kok Award for best dissertation of the year 2015
Koen van der Maaden PhD, Development Officer at MyLife Technologies, has won the C.J. Kok Award for best dissertation of the year 2015! Koen van der Maaden’s research, described in his thesis “Microneedle-mediated vaccine delivery” on which he recently obtained his PhD degree cum laude, has brought painless vaccination using microneedles major steps forward. From the jury report: “The jury of the C.J. Kok prize was impressed by the excellence of the scientific work, the broad array of techniques applied by Koen and the major societal impact of the research. Microneedles are not only painless, they will also allow more easy storage of vaccines in dry form and thus eliminating the requirement for refrigeration and the applicator designed will upon further development allow administration by non-medical personnel. Koen’s discoveries thus have brought future application of worldwide painfree vaccination against diseases-like the measles, polio and other infectious diseases important steps closer.” http://www.universiteitleiden.nl/en/news/2016/01/discoverer-of-the-year-best-dissertation-and-education-prize-2015
- 'Eight innovations from scientific start-ups' on the website of Dutch government:
- In 'Radio EenVandaag'; an interview with Pieter Jan Vos (Spoken Dutch):
- Marijke Roskam of BNR news radio interviews Pieter Jan Vos (Spoken Dutch):